Roles of adipose tissue-derived factors in obesity

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 4, 2006, Pages 537-543

  Umpaichitra, Vatcharapan ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Adipose tissue; Factor; Obesity

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; ADIPSIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; GLUCOCORTICOID; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENERGY METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ADIPOSE TISSUE; CHILD; ENDOCRINE SYSTEM; ENERGY METABOLISM; HORMONES; HUMANS; OBESITY;

EID: 33846547033     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Klaus S. Adipose tissue as a regulator of energy balance. Current Drug Targets 2004;5:241-250
2. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556
3. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355
4. Ferroni P, Basili S, Falco A, Davi G. Inflammation, insulin resistance, and obesity. Curr Sci 2004;6:424-431
5. Abate N, Garg A. Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 1995;34:53-70
6. Pond CM. Physiological specialization of adipose tissue. Prog Lipid Res 1999;38:225-248
7. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 2004;12:1197-1211
8. Duntas LH, Popovic V, Panotopoulos G. Adiponectin: Novelties in metabolism and hormonal regulation. Nutr Neurosci 2004;7:195-200
9. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Int Med 2005;257:167-175
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432
11. Cancello R, Tounian A, Poitou C, Clement K. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004;30:215-227
12. Peter MA, Winterhalter KH, Boni-Schnetzler M, Froesch ER, Zapf J. Regulation of insulin-like growth factor-1 (IGF-I) and IGF-binding proteins bt growth hormone in rat white adipose tissue. Endocrinology 1993;133:2624-2631
13. Alessi M, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000;49:1374-1380
14. Mishra L, Derynck R, Mishra B. Transforming growth factor-β signaling in stem cells and cancer. Science 2005;310:68-71
15. Trayhurn P. Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005;184:285-293
16. Wang B, Jenkins JR, Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 2005;288:E731-E740
17. Fain JN, Madan AK, Hiler L, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese human. Endocrinology 2004;145:2273-2282
18. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-282
19. Ruggeri RB. Cholesteryl ester transfer protein: pharmacological inhibition for the modulation of plasma cholesterol levels and promising target for the prevention of atherosclerosis. Curr Top Med Chem 2005;5:257-264
20. Radeau T, Robb M, McDonnell M, McPherson R. Preferential expression of cholesteryl ester transfer protein mRNA by stromal-vascular cells of human adipose tissue. Biochem Biophys Acta 1998;1392:245-253
21. Zechner R, Moser R, Newman TC, Fried SK, Breslow JL. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem 1991;266:10583-10588
22. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, Blaner WS. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 1992;267:1805-1810
23. Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin expression in genetic and acquired obesity. Science 1987;237:405-408
24. White R, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. Human adipsin is identical to complement factor D and its expressed at high levels in adipose tissue. J Biol Chem 1992;267:9210-9213
25. Choy LN, Spiegelman BM. Regulation of alternative pathway activation and C3a production by adipose cells. Obes Res 1996;4:521-532
26. Gabrielsson BG, Johansson JM, Lonn M, Jernas M, Olbers T, Peltonen M, Larsson I, Lonn L, Sjostrom L, Carlsson B, Carlsson LM. High expression of complement components in omental adipose tissue in obese men. Obes Res 2003;11:699-708
27. Napolitano A, Lowell BB, Damm D, Leibel RL, Ravussin E, Jimerson DC, Lesem MD, Van Dyke DC, Daly PA, Chatis P, White RT, Spiegelman BM, Flier JS. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994;18:213-218
28. Gabay C, Hushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454
29. Do MS, Nam SY, Hong SE, Kim KW, Duncan JS, Beattie JH, Trayhurn P. Metallothionein gene expression in human adipose tissue from lean and obese subjects. Horm Metab Res 2002;34:348-351
30. Crandall DI, Gordon G, Herzlinger HE, Saunders BD, Zolotor RC, Cervoni P, Krai JG. Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats. Eur J Clin Invest 1992;22:676-680
31. Rogriguez AM, Elabd C, Delteil F, Astier J, Vernochet C, Saint-Marc P, Guesnet J, Guezennec A, Amri EZ, Dani C, Ailhaud G. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun 2004;315:255-263
32. Fain JN, Kanu A, Bahouth SW, Cowan GS Jr, Hiler ML, Leffler CW. Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins Leukot Essent Fatty Acids 2002;67:467-473
33. Abe R, Shimizu T, Sho-ichi Y, Shibaki A, Amano S, Inagaki Y, Watanabe H, Sugawara H, Nakamura H, Takeuchi M, Imaizumi T, Shimizu H. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathl 2004;164:1225-1232
34. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, Bickel PE, Anderson JS, Fernandez MM, Bunkenborg J, Roepstorff P, Kristiansen K, Lodish HF, Mann M, Pandey A. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002;1:213-222
35. Wilkinson WO, Spiegelman BM. Biosynthesis of the vasoactive lipid monobutyrin. Central role of diacylglycerol. J Biol Chem 1993;268:2844-2849
36. Korn ED, Quigley TW Jr. Studies of lipoprotein lipase of rat heart and adipose tissue. Biochim Biophys Acta 1955;18:143-145
37. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005;54:1023-1031
38. Seckl JR, Morton NM, Chapman KE, Walker BR. Glucocorticoids and 11-beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 2004;59:359-393
39. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003;1609:127-143
40. Cianflone K, Lu H, Smith J, Yu W, Wang H. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol 2005;62:567-572
41. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richard S GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271
42. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002;34:616-621
43. Park K, Park KS, Kim M, Kim H, Suh Y, Ahn J, Park K, Chang Y, Lee I. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Prac 2004;63:135-142
44. Staiger H, Tschritter O, Machann J, Thaner C, fritsche A, Maerker E, Schick F, Haring H, Stumvoll M. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003;11:368-372
45. Havel PJ. Regulatory of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53(Suppl 1):S143-S151
46. Hellstrom PM, Geliebter A, naslund E, Schmidt PT, Yahav EK, Hashim SA, Yeomans MR. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr 2004;92:s47-s57
47. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004;30:13-19
48. Oettgen HF, Carswell EA, Kassel RL, Fiore N, Williamson B, Hoffmann MK, Haranaka K, Old LJ. Recent Results Cancer Res 1980;75:207-212
49. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002;96:594-598
50. Lazar G Jr, Duda E, Lazar G. Effect of RU 38486 on TNF production and toxicity. FEBS Lett 1992;308:137-140
51. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415
52. You T, Yang R, Lyles MF, Gong D, Nicklas BJ. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 2005;288:E741-E747
53. Kellerer M, Rett K, Renn W, Groop L, Haring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996;28:737-743
54. Hotamisligil GS, Shargilt NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha:direct role in obesity-linked insulin resistance. Science 1993;259:87-91
55. Youn B, Min SS, Park KS, Lee HW, Yu R, Kwon BS. The role of adipocytokines in adipocyte-related pathological processes. Drug News Perspect 2004;17:293-298
56. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-1801
57. Umpaichitra V, Hussain MM, Castells C. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity. Pediatr Res 2005;58:483-487
58. Lapolla A, Piarulli F, Sartore G, Rossetti C, Martana L, Carraro P1 De Paoli M, Fedele D. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis. Thromb Haemost 2003;89:91-96
59. Hernandez C, Chacon P, Garcia-Pascual L, Mesa J, Simo R. Relationship between lipoprotein(a) phenotypes and plasminogen activator inhibitor 1 in diabetic patients. Thromb Res 2000;99:119-127
60. Calles-Escandon J, Mirza SA, Sobel BE, Schneider DJ. Induction of hyper insulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 1998;47:290-293
61. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312
62. Fain JN, Cheema PS, Bahouth SW, Hiler ML. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003;300:674-678
63. Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90:2282-2289
64. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to Ciq, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749
65. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286-289
66. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996;120:803-812
67. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703
68. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83
69. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:2442-2449
70. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001;288:1102-1107
71. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakame T, Kodera K, Shirahata A, Taniyana M. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003;11:1072-1079
72. Cote M, Mauriege P, Bergeron J, Almeras N, Tremblay A, Lemieux I, Despres J. Adiponectinemia in visceral obesity: Impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005;90:1434-1439
73. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002;87:5662-5667
74. Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004;53:123-129
75. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clinica Chemica Acta 2004;344:1-12
76. Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol 2004;61:418-423
77. Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002;34:469-474
78. Yamaguchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Ushida S, Takekawa S, Waki H, Tsumo NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-769
79. Gil-Campos M, Canete R, Gil A. Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int J Obes 2004;28:575-580
80. Dunger D, Ong K. Abundance of adiponectin in the newborn. Clin Endocrinol 2004;61:416-417
81. Iniguez G, Soto N, Avila A, Salazar T, Ong K, Dunger D. Adiponectin levels in the first two years of life in a prospective cohort: Relations with weight gain, leptin levels and insulin sensitivity. J Clin Endocrinol Metab 2004;89:5500-5503
82. Cianfarani S, Martinez C, Maiorana A, Scire G, Spadoni GL, Boemi S. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab 2004;89:1346-1351
83. Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2004;55-62
84. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni A. Plasma adiponectin concentrations in children: Relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002;87:4652-4656
85. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, Caprio S. Low adiponectin levels in adolescents obesity: A marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003;88:2014-2018
86. Diamond FB, Cuthbertson D, Hanna S, Eichler D. Correlates os adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 2004;17:1069-1075
87. Bacha F, Saad R, Gungor N, Arslanian S. Adiponectin in youth. Diabetes Care 2004;27:547-552
88. Abasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004;53:585-590
89. Harrington TAM, Thomas EL, Frost G, Modi N, Bell JD. Distribution of adipose tissue in the newborn. Pediatr Res 2004;55:437-441
90. Harrington TAM, Thomas EL, Modi N, Frost G, Coutts GA, Bell JD. Fast and reproducible method for the direct quantitation of adipose tissue in newborn infants. Lipids 2002;37:95-100
91. Goran MI, Kaskoun M, Shuman WP. Intra-abdominal adipose tissue in young children. Int J Obes Metab Disord 1995;19:279-283
92. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:137-144
93. Hofman PL, Regan F, Jackson WE, Craig J, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med 2004;18:2179-2231
94. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-3794
95. Yang W, Lee W, Funahashi T, Tanaka S, Matsuzawa Y, Chao C, Chen C, Tai T, Chuang L. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819
96. Umpaichitra V, Mercado AB, Juan C, Quintos JB, Castells S. Adiponectin responses to oral glucose tolerance tests in adolescents with morbid obesity. E-PAS 2006;59:3515.130
97. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Res 2004;12:962-971